MediWound (MDWD) Retained Earnings (2013 - 2026)
MediWound (MDWD) posted quarterly Retained Earnings of -$228.9 million for Q4 2025, down 11.65% year-over-year from -$259.1 million in Q4 2024, and down 4.49% quarter-over-quarter from -$219.1 million in Q2 2025.
MediWound (MDWD) Retained Earnings (2013 - 2026) Analysis & Trends
MediWound's Retained Earnings history runs 13 years deep, the most recent figure standing at -$228.9 million for Q4 2025.
- In Q4 2025, Retained Earnings fell 11.65% year-over-year to -$228.9 million; the TTM figure through Dec 2025 stood at -$228.9 million (down 11.65% YoY), while the FY2025 annual figure was -$228.9 million, down 11.65% from the prior year.
- Retained Earnings for Q4 2025 stood at -$228.9 million, down from -$219.1 million in the prior quarter.
- The five-year high for Retained Earnings was -$137.8 million in Q1 2021, with the low at -$228.9 million in Q4 2025.
- The 5-year median for Retained Earnings is -$164.4 million (2022), against an average of -$171.3 million.
- The sharpest annual moves came in 2023 and 2024: Retained Earnings fell 4.0% in 2023, then decreased 17.29% in 2024.
- MediWound's Retained Earnings stood at -$148.5 million in 2021, then retreated by 13.2% to -$168.1 million in 2022, then declined by 4.0% to -$174.8 million in 2023, then dropped by 17.29% to -$205.0 million in 2024, then retreated by 11.65% to -$228.9 million in 2025.
- Business Quant data shows MDWD's Retained Earnings at -$228.9 million in Q4 2025, -$219.1 million in Q2 2025, and -$205.0 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 4.38 Bn |
| 10 | MediWound | 170.65 Mn | 139.65 Mn | 337,000.00 | -239.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -239.30 Mn |
| Dec 31, 2025 | -228.93 Mn |
| Jun 30, 2025 | -219.09 Mn |
| Dec 31, 2024 | -205.05 Mn |
| Jun 30, 2024 | -190.86 Mn |
| Dec 31, 2023 | -174.82 Mn |
| Jun 30, 2023 | -170.88 Mn |
| Dec 31, 2022 | -168.11 Mn |
| Sep 30, 2022 | -160.65 Mn |
| Jun 30, 2022 | -156.45 Mn |
| Mar 31, 2022 | -152.10 Mn |
| Dec 31, 2021 | -148.51 Mn |
| Sep 30, 2021 | -144.35 Mn |
| Jun 30, 2021 | -141.00 Mn |
| Mar 31, 2021 | -137.81 Mn |
| Dec 31, 2020 | -134.96 Mn |
| Sep 30, 2020 | -133.22 Mn |
| Jun 30, 2020 | -131.32 Mn |
| Mar 31, 2020 | -128.22 Mn |
| Dec 31, 2019 | -125.76 Mn |